Cargando…

Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)

BACKGROUND AND AIM: In Qatar, the prevalence of metabolic syndrome (MetS) in children and adults is increasing in parallel with the markedly increasing trends in obesity rates. OBJECTIVE: The aim of our study was to assess the prevalence of different components of MetS, measure plasma atherogenic in...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Noor, Soliman, Ashraf, De Sanctis, Vincenzo, Shaat, Mona, Alaaraj, Nada, Ahmed, Shaymaa, Qusad, Mohammad, Siddiq, Khalid, Alyafei, Fawzia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686177/
https://www.ncbi.nlm.nih.gov/pubmed/36300244
http://dx.doi.org/10.23750/abm.v93i5.12679
_version_ 1784835685322063872
author Hamed, Noor
Soliman, Ashraf
De Sanctis, Vincenzo
Shaat, Mona
Alaaraj, Nada
Ahmed, Shaymaa
Qusad, Mohammad
Siddiq, Khalid
Alyafei, Fawzia
author_facet Hamed, Noor
Soliman, Ashraf
De Sanctis, Vincenzo
Shaat, Mona
Alaaraj, Nada
Ahmed, Shaymaa
Qusad, Mohammad
Siddiq, Khalid
Alyafei, Fawzia
author_sort Hamed, Noor
collection PubMed
description BACKGROUND AND AIM: In Qatar, the prevalence of metabolic syndrome (MetS) in children and adults is increasing in parallel with the markedly increasing trends in obesity rates. OBJECTIVE: The aim of our study was to assess the prevalence of different components of MetS, measure plasma atherogenic indexes (AIP), and to evaluate linear growth in young obese nondiabetic children (< 5 years) in comparison to older obese children (6-12 years). METHODS: We analysed the anthropometric and biochemical profile of 135 random sample obese children who attended to the Paediatric Clinic of Hamad Medical Centre (HGH) in Doha (Qatar) from January 2018 to December 2019. RESULTS: A large proportion of children presented with obesity, around the age of 5 years, were obese at the end of their first year of life (63.8%) and more were obese at the 2 years of age (82.6%). Significantly rapid gain in weight and linear growth occurred during the first 6 months of postnatal life. Moreover, some metabolic risk factors and high AIP occurred more frequently in older obese children compared to young obese children. CONCLUSIONS: This study documented the early occurrence of different components of the MetS in young obese children and the progressive increase of their prevalence in older prepubertal children. Most of obese children who presented at or below 5 years of age had significant obesity and rapid linear growth during the first two years (infancy). These two findings pointed out to the necessity to impose early detection and preventive measures on a national scale. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-9686177
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-96861772022-12-05 Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years) Hamed, Noor Soliman, Ashraf De Sanctis, Vincenzo Shaat, Mona Alaaraj, Nada Ahmed, Shaymaa Qusad, Mohammad Siddiq, Khalid Alyafei, Fawzia Acta Biomed Original Article BACKGROUND AND AIM: In Qatar, the prevalence of metabolic syndrome (MetS) in children and adults is increasing in parallel with the markedly increasing trends in obesity rates. OBJECTIVE: The aim of our study was to assess the prevalence of different components of MetS, measure plasma atherogenic indexes (AIP), and to evaluate linear growth in young obese nondiabetic children (< 5 years) in comparison to older obese children (6-12 years). METHODS: We analysed the anthropometric and biochemical profile of 135 random sample obese children who attended to the Paediatric Clinic of Hamad Medical Centre (HGH) in Doha (Qatar) from January 2018 to December 2019. RESULTS: A large proportion of children presented with obesity, around the age of 5 years, were obese at the end of their first year of life (63.8%) and more were obese at the 2 years of age (82.6%). Significantly rapid gain in weight and linear growth occurred during the first 6 months of postnatal life. Moreover, some metabolic risk factors and high AIP occurred more frequently in older obese children compared to young obese children. CONCLUSIONS: This study documented the early occurrence of different components of the MetS in young obese children and the progressive increase of their prevalence in older prepubertal children. Most of obese children who presented at or below 5 years of age had significant obesity and rapid linear growth during the first two years (infancy). These two findings pointed out to the necessity to impose early detection and preventive measures on a national scale. (www.actabiomedica.it) Mattioli 1885 2022 2022-10-26 /pmc/articles/PMC9686177/ /pubmed/36300244 http://dx.doi.org/10.23750/abm.v93i5.12679 Text en Copyright: © 2022 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Hamed, Noor
Soliman, Ashraf
De Sanctis, Vincenzo
Shaat, Mona
Alaaraj, Nada
Ahmed, Shaymaa
Qusad, Mohammad
Siddiq, Khalid
Alyafei, Fawzia
Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)
title Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)
title_full Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)
title_fullStr Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)
title_full_unstemmed Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)
title_short Linear growth and prevalence of the different components of the metabolic syndrome (MetS) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)
title_sort linear growth and prevalence of the different components of the metabolic syndrome (mets) in young obese nondiabetic children (below 5 years) in comparison to older obese children (6-12 years)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686177/
https://www.ncbi.nlm.nih.gov/pubmed/36300244
http://dx.doi.org/10.23750/abm.v93i5.12679
work_keys_str_mv AT hamednoor lineargrowthandprevalenceofthedifferentcomponentsofthemetabolicsyndromemetsinyoungobesenondiabeticchildrenbelow5yearsincomparisontoolderobesechildren612years
AT solimanashraf lineargrowthandprevalenceofthedifferentcomponentsofthemetabolicsyndromemetsinyoungobesenondiabeticchildrenbelow5yearsincomparisontoolderobesechildren612years
AT desanctisvincenzo lineargrowthandprevalenceofthedifferentcomponentsofthemetabolicsyndromemetsinyoungobesenondiabeticchildrenbelow5yearsincomparisontoolderobesechildren612years
AT shaatmona lineargrowthandprevalenceofthedifferentcomponentsofthemetabolicsyndromemetsinyoungobesenondiabeticchildrenbelow5yearsincomparisontoolderobesechildren612years
AT alaarajnada lineargrowthandprevalenceofthedifferentcomponentsofthemetabolicsyndromemetsinyoungobesenondiabeticchildrenbelow5yearsincomparisontoolderobesechildren612years
AT ahmedshaymaa lineargrowthandprevalenceofthedifferentcomponentsofthemetabolicsyndromemetsinyoungobesenondiabeticchildrenbelow5yearsincomparisontoolderobesechildren612years
AT qusadmohammad lineargrowthandprevalenceofthedifferentcomponentsofthemetabolicsyndromemetsinyoungobesenondiabeticchildrenbelow5yearsincomparisontoolderobesechildren612years
AT siddiqkhalid lineargrowthandprevalenceofthedifferentcomponentsofthemetabolicsyndromemetsinyoungobesenondiabeticchildrenbelow5yearsincomparisontoolderobesechildren612years
AT alyafeifawzia lineargrowthandprevalenceofthedifferentcomponentsofthemetabolicsyndromemetsinyoungobesenondiabeticchildrenbelow5yearsincomparisontoolderobesechildren612years